Lab of ImmunoEngineering and ImmunoTheranostics VCU School of Pharmacy

Home

Research


“Very recent research efforts in the lab concern combination cancer immunotherapy based on nanovaccines and nanomedicines, mRNA therapeutics, STING-activating immunomodulators, and gene-editing nanomedicines. “

Our Research


The Work We Do


Our research interests lie at the interface of immune-oncology, nucleic acid therapeutics, nanomedicine, pharmacoengineering and pharmacoimaging. My current focus is to develop “off-the-shelf” nucleic acid nanomedicines to modulate the immune system to treat cancer, and to interrogate the immuno-nano interfaces. My long-term goal is to implement immunotherapy to a broad population of patients. These interests often involve the following areas:

  • ImmunoEngineering
  • ImmunoTheranostics
  • Nanovaccine
  • Nanomedicine
  • Nucleic acid therapeutics and probes (immunomodulatory DNA/RNA, mRNA, siRNA/shRNA, plasmid, Aptamer, etc)
  • Cancer and immune disorders


Very recent research efforts in the lab concern combination cancer immunotherapy based on nanovaccines and nanomedicines, mRNA therapeutics, STING-activating immunomodulators, and gene-editing nanomedicines.